Carlyle Group Inc.Carlyle Group Inc.

Institutional investor · Portfolio as of Q1 2021

SEC EDGAR SourceSEC Filings

Top Holdings12 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

ZOOMINFO TECHNOLOGIES INC

89.3M$4.4B33.0%$50.72-3.39%
4 qtrssince 2020-Q2
Decreased
0
ATCATCDelisted

ATOTECH LTD

153.7M$3.1B23.5%
1 qtr
New
100
OCDXOCDXDelisted

ORTHO CLINICAL DIAGNOSTICS H

143.4M$2.8B20.9%
1 qtr
New
100
PPDPPDDelisted

PPD INC

55.7M$2.1B16.0%
5 qtrssince 2020-Q1
Unchanged
0
ONEMONEMDelisted

1LIFE HEALTHCARE INC COM

13.6M$532M4.0%
5 qtrssince 2020-Q1
Unchanged
0

LIBERTY ENERGY INC

12.3M$138.9M1.1%$11.90+86.89%
10 qtrssince 2018-Q4
Decreased
0
VTRUVTRUDelisted

VITRU LTD

6.2M$92.8M0.7%
3 qtrssince 2020-Q3
Unchanged
0

TALOS ENERGY INC

5M$59.7M0.5%$5.70+113.33%
5 qtrssince 2020-Q1
Unchanged
0
7.9M$21.1M0.2%
10 qtrssince 2018-Q4
Unchanged
0
587,838$10.4M0.1%$20.12-3.78%
4 qtrssince 2020-Q2
Unchanged
0

SEACOR MARINE HLDGS INC

1.1M$6.1M0.0%$11.28-52.94%
10 qtrssince 2018-Q4
Unchanged
0

SIRIUSPOINT LTD

129,408$1.3M0.0%$10.290.00%
1 qtr
New
38
$13.2B
AUM
12
Positions
Q1 2021
Filing
Rating · 1.5
Quarterly Portfolio Change
-17%Q3'20$7.3B+2%Q4'20$7.5B+77%Q1'21$13.2B
Activity profile
$ moved · Q1'21
New95%Increased0%Decreased5%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.9 quarters
<1Q25%1-4Q25%1-2Y25%2Y+25%

Carlyle Group Inc. manages $13.2B across 12 positions as of Q1 2021. Top holdings: GTM (33.0%), ATC (23.5%), OCDX (20.9%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 1.5/5.0.

Q1 2021 Summary

Added 3 new positions, exited 1, trimmed 2. Top move: ATC (NEW, conviction 100). Portfolio: $13.2B across 12 positions.

Top holdings by portfolio weight

Total AUM$13B
GTM33.04%
ATC23.55%
OCDX20.94%
PPD15.95%
ONEM4.03%
LBRT1.05%
VTRU0.70%
TALO0.45%
ONESMART INT0.16%
PHYSICIANS R0.08%
Other0.05%

Portfolio allocation by GICS sector

Sectors6
Unknown65.27%
Technology33.09%
Energy1.51%
Real Estate0.08%
Industrials0.05%
Financial Services0.01%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Unknown, Technology
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track RecordNo data
Conviction38
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used